Nosocomial candidaemia in a Finnish tertiary care centre during 1987-2004

Scandinavian Journal of Infectious Diseases

Volumn 41, Issue 8, 2009, Pages 590-596

  Poikonen, Eira ^a   Lyytikäinen, Outi ^b   Anttila, Veli Jukka ^c   Kuusela, Pentti ^c   Koukila Kähkölä, Pirkko ^c   Ollgren, Jukka ^b   Ruutu, Petri ^b  

^a PEIJAS HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDEMIA; CHILD; CONTROLLED STUDY; FEMALE; FINLAND; FUNGUS CULTURE; FUNGUS ISOLATION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; SCHOOL CHILD; TERTIARY HEALTH CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CANDIDA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; FINLAND; FUNGEMIA; HOSPITALS; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; MORTALITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 70849113816     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540903022824     Document Type: Article

References (25)

1. Morgan J, Meltzer MI, Plikaytis BD, Sofair AN, Huie-White S, Wilcox S, et al. Excess mortality, hospital stay, and cost due to candidaemia: a case-control study using data from population-based candidaemia surveillance. Infect Control Hosp Epidemiol 2005;/26:/540-7.
2. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;/20:/ 1526-1530
3. Hajjeh RA, Sofair AN, Harrison LH, Lyon GM, Arthington- Skaggs BA, Mirza SA, et al. Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population based active surveillance programme. J Clin Microbiol 2004;/42:/ 1519-1527
4. MacDonald L, Baker C, Chenoweth C. Risk factors for candidaemia in a children's hospital. Clin Infect Dis 1998;/ 26:/642-5.
5. Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007;/20:/133-63.
6. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in U.S. hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004;/39:/ 309-317
7. Kibbler CC, Seaton S, Barnes RA, Gransden WR, Holliman RE, Johnson EM, et al. Management and outcome of bloodstream infections due to Candida species in England and Wales. J Hosp Infect 2003;/54:/18-24.
8. Luzzati R, Amalfitano G, Lazzarini L, Soldani F, Bellino S, Solbiati M, et al. Nosocomial candidaemia in non-neutropenic patients at an Italian tertiary care hospital. Eur J Clin Microbiol Infect Dis 2000;/19:/602-7.
9. Marchetti O, Bille J, Fluckiger U, Eggimann P, Ruef C, Garbino J, et al. Epidemiology of candidaemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis 2004;/38:/311-20.
10. San Miguel LG, Cobo J, Otheo E, Sanchez-Sousa A, Abraira V, Moreno S. Secular trends of candidaemia in a large tertiary care hospital from 1988 to 2000: emergence of Candida parapsilosis. Infect Control Hosp Epidemiol 2005;/ 26:/548-52.
11. Tortorano AM, Peman J, Bernhardt H, Klingspor L, Kibbler CC, Faure O, et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004;/23:/317-22.
12. Voss A, Kluytmans JA, Koeleman JG, Spanjaard L, Vandenbroucke- Grauls CM, Verbrugh HA, et al. Occurrence of yeast bloodstream infections between 1987 and 1995 in 5Dutch university hospitals. Eur J Clin Microbiol Infect Dis 1996;/15:/909-12.
13. Lagrou K, Verhaegen J, Peetermans WE, de Rijdt T, Maertens J, van Wijngaerden E. Fungemia at a tertiary care hospital: incidence, therapy, and distribution and antifungal susceptibility of causative species. Eur J Clin Microbiol Infect Dis 2007;/26:/541-7.
14. Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, et al. Epidemiology of candidaemia: 3-y results from the Emerging Infections and the Epidemiology of Iowa Organisms study. J Clin Microbiol 2002;/40:/1298-302.
15. Kao AS, Brandt ME, Pruitt WR, Conn LA, Perkins BA, Stephens DS, et al. The epidemiology of candidaemia in 2 United States cities: results of a population based active surveillance. Clin Infect Dis 1999;/29:/1164-70.
16. Asmundsdottir LR, Erlendsdottir H, Gottfredsson M. Increasing incidence of candidaemia: results from a 20-y nationwide study in Iceland. J Clin Microbiol 2002;/40:/ 3489-3492
17. Poikonen E, Lyytikainen O, Anttila VJ, Ruutu P. Candidaemia in Finland, 1995-1999. Emerg Infect Dis 2003;/9:/ 985-990
18. Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsaker T, Gaustad P. Candidaemia in Norway, 1991-2003: results from a nationwide study. J Clin Microbiol 2006;/44:/1977-81.
19. Arendrup MC, Fuursted K, Gahrn-Hansen B, Schonheyder HC, Knudsen JD, Jensen IM, et al. Semi-national surveillance of fungaemia in Denmark, 2004-2006: increasing incidence of fungaemia and numbers of isolates with reduced azole susceptibility. Clin Microbiol Infect 2008;/14:/487-94.
20. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital acquired candidaemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis 2002;/35:/627-30.
21. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;/16:/128-40.
22. Lyytikainen O, Lumio J, Sarkkinen H, Kolho E, Kostiala A, Ruutu P. Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis 2002;/35:/14-9.
23. Sarvikivi E, Lyytikainen O, Soll DR, Pujol C, Pfaller MA, Richardson M, et al. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J Clin Microbiol 2005;/43:/ 2729-2735
24. Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, et al. The epidemiology of Candida glabrata and Candida albicans fungaemia in immunocompromized patients with cancer. Am J Med 2002;/112:/380-5.
25. Pfaller MA, Diekema DJ. 12 y of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 2004;/10(Suppl 1):/11-23.